Compare NVO & PG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVO | PG |
|---|---|---|
| Founded | 1923 | 1837 |
| Country | Denmark | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 199.4B | 346.1B |
| IPO Year | 2001 | 2014 |
| Metric | NVO | PG |
|---|---|---|
| Price | $39.58 | $166.27 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 14 | 25 |
| Target Price | $45.80 | ★ $161.65 |
| AVG Volume (30 Days) | ★ 9.1M | 5.9M |
| Earning Date | 11-04-2026 | 10-22-2026 |
| Dividend Yield | ★ 3.28% | 2.78% |
| EPS Growth | N/A | ★ 1.69 |
| EPS | N/A | ★ 6.62 |
| Revenue | N/A | ★ $87,032,000,000.00 |
| Revenue This Year | N/A | $2.10 |
| Revenue Next Year | $1.28 | $3.03 |
| P/E Ratio | ★ $13.60 | $23.76 |
| Revenue Growth | N/A | ★ 3.26 |
| 52 Week Low | $35.12 | $137.62 |
| 52 Week High | $64.16 | $167.25 |
| Indicator | NVO | PG |
|---|---|---|
| Relative Strength Index (RSI) | 47.46 | 75.35 |
| Support Level | $38.02 | $141.89 |
| Resistance Level | $39.58 | $167.25 |
| Average True Range (ATR) | 0.66 | 2.47 |
| MACD | 0.41 | 1.21 |
| Stochastic Oscillator | 89.73 | 95.82 |
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the world's leading provider of diabetes care products. Based in Denmark, the company manufactures and markets a variety of human and modern insulins for patients with diabetes, as well as injectable and oral GLP-1 therapies, across its obesity and diabetes care segment. Novo also has a rare disease segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Since its founding in 1837, Procter & Gamble has become one of the world's largest consumer product manufacturers, with annual sales of more than $87 billion. It operates with a lineup of leading brands, including more than 20 that generate annual global sales of more than $1 billion each, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside the US represent just over half of the firm's consolidated total.